FMP

FMP

Enter

Chardan Capital Markets analysts initiated coverage on iBio (NYSE:IBIO) with a Buy rating and a price target of $5, noting they see significant potential in iBi

iBio Started With a Buy Rating at Chardan Capital

-

twitterlinkedinfacebook
blog post cover photo

Image credit: FMP

Chardan Capital Markets analysts initiated coverage on iBio (NYSE:IBIO) with a Buy rating and a price target of $5, noting they see significant potential in iBio's proprietary AI-guided drug discovery platform, which aims to create next-generation engineered antibodies for challenging targets while reducing development risks.

This marks a strategic shift for iBio, which acquired RubrYc Therapeutics in September 2022 for its AI-driven drug discovery capabilities and decided to divest its CDMO facility in November 2022, resulting in a workforce reduction of about 60%. iBio's recent partnership with AstralBio focuses on developing novel antibodies to treat obesity and other cardiometabolic conditions.

The analysts believe iBio has evolved into an intriguing micro-cap investment opportunity, suitable for investors with a longer-term perspective who are willing to balance the company's need to raise additional capital (expected in the first half of 2025) before any human clinical data is available. The core technology behind iBio's platform combines precision medicine biology with machine learning and AI.

Other Blogs

Nov 25, 2023 6:39 AM - Parth Sanghvi

DCF Valuation vs. Comparable Companies Analysis: Choosing the Right Valuation Method

Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...

blog post title

Dec 23, 2023 2:19 AM - Parth Sanghvi

Understanding the Limitations of DCF Analysis: A Guide to Overcoming Challenges

Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...

blog post title

Dec 25, 2023 2:28 AM - Parth Sanghvi

Integrating Sustainability into Valuations: Navigating ESG Factors within the Discounted Cash Flow (DCF) Model

Introduction: The investment landscape is undergoing a profound shift with a heightened emphasis on sustainability and responsible investing. In this blog post, we explore the intersection of Environmental, Social, and Governance (ESG) considerations within the Discounted Cash Flow (DCF) model, h...

blog post title
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep